1. Bourlioux P, Koletzko B, Guarner F, Braesco V. The intestine and its microflora are partners for the protection of the host: report on the Danone symposium “The Intelligent Intestine,” held in Paris, June 14, 2002. Am J Clin Nutr. 2003; 78:675–683.
Article
2. Lavelle A, Hill C. Gut microbiome in health and disease: emerging diagnostic opportunities. Gastroenterol Clin North Am. 2019; 48:221–235.
3. Villanueva-Millán MJ, Pérez-Matute P, Oteo JA. Gut microbiota: a key player in health and disease. A review focused on obesity. J Physiol Biochem. 2015; 71:509–525.
Article
4. Song KH, Jung HK, Min BH, et al. Development and validation of the Korean Rome III questionnaire for diagnosis of functional gastrointestinal disorders. J Neurogastroenterol Motil. 2013; 19:509–515.
Article
5. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997; 11:395–402.
Article
6. Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci. 1998; 43:400–411.
7. Frank L, Kleinman L, Farup C, Taylor L, Miner P Jr. Psychometric validation of a constipation symptom assessment questionnaire. Scand J Gastroenterol. 1999; 34:870–877.
8. Drossman DA, Li Z, Toner BB, et al. Functional bowel disorders. A multicenter comparison of health status and development of illness severity index. Dig Dis Sci. 1995; 40:986–995.
9. Kwon S, Jung HK, Hong JH, Park HS. Diagnostic validity of the Korean gastrointestinal symptom rating scale (KGSRS) in the assessment of gastro-esophageal reflux disease. Ewha Med J. 2008; 31:73–80.
Article
10. Drossman DA, Hasler WL. Rome IV-functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 2016; 150:1257–1261.
Article